UNLOCKING THE PROMISE OF MEDTECH
Generating Value for Companies, Investors & Patients
The global MedTech market presents a unique and under-served opportunity for companies and their investors.
MedTech consistently drives advances in medical therapy, healthcare delivery, data management, healthcare technology, and diagnostics that will shape the future of patient care.
MedTech deals in systemic solutions for larger populations. It deploys engineering and other technologies often developed outside of the healthcare field, as well as established clinical principles, delivered or applied in novel ways. As a result, MedTech provides a predictable and rewarding investment strategy for those interested in the healthcare sector.
The value of these leading-edge technologies is growing rapidly in the face of aging populations and increased incidence of chronic disease, increasing healthcare expenditures and growing pressure to control this spending. Given these global dynamics, we believe that providing investment capital as well as expertise to the MedTech sector, both for companies seeking growth capital in the $15M-$100M range, as well as for those seeking early-stage funding, is an unheralded opportunity.
BioVentures MedTech Funds have the team and processes in place to help our portfolio companies realize their full potential — contributing to patient care and ensuring rewarding exits for portfolio management teams and our limited partner investors.
MEDTECH MEETS THE CHALLENGE
There is a pressing need for medical technologies that can help better manage chronic diseases, curtail hospital re-admission, provide meaningful and actionable diagnosis and disease monitoring, and reduce individual procedural as well as system-wide costs.
With its breadth of technologies, the MedTech sector is well positioned to tackle these challenges.